GGrantIndex
← Leaderboards

Eric A Boerwinkle

University Of Texas Hlth Sci Ctr Houston

$148,432,538
Attributed
$278,154,563
Total exposure
20
Grants
13
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $47.3M · FY200525
$50M$37.5M$25M$12.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$278,154,563 · 20

By mechanism

OT2$156,509,166 · 2
R01$39,747,209 · 8
U01$38,891,830 · 5
RC2$27,554,408 · 1
R37$10,791,888 · 1
P50$4,216,433 · 2

Top collaborators

Most similar at University Of Texas Hlth Sci Ctr Houston

Same institution · by research overlap

Others in their field

Top investigators on “Variant

Research focus

VariantGenotypeGenesSamplingAfrican AmericanGeneticParticipantCommunitiesAlzheimer&AposResearch PersonnelGenomeProgramsGenomicsPhenotypeCohortResourcesGenome Wide Association StudyCollaborationsAtherosclerosisBaseRisk FactorsSingle Nucleotide PolymorphismEnvironmentBioinformatics

Grant awards (88)

Add Health Parent Study: A Biosocial Resource for the Study of Multigenerational Racial/Ethnic Disparities in Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD)$7,584,228
R01 · FY2025 · AG
All of Us at the Baylor-Hopkins Clinical Genome Center$700,000
OT2 · FY2025 · OD
Add Health Parent Study: A Biosocial Resource for the Study of Multigenerational Racial/Ethnic Disparities in Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD)$6,257,619
R01 · FY2024 · AG
All of Us at the Baylor-Hopkins Clinical Genome Center$2,999,317
OT2 · FY2024 · OD
The Baylor-Hopkins Clinical Genomics Center for All of Us$10,200,000
OT2 · FY2023 · OD
Add Health Parent Study: A Biosocial Resource for the Study of Multigenerational Racial/Ethnic Disparities in Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD)$3,197,669
R01 · FY2023 · AG
The Baylor-Hopkins Clinical Genomics Center for All of Us$33,999,970
OT2 · FY2022 · OD
Therapeutic target discovery in ADSP data via comprehensive whole-genome analysis incorporating ethnic diversity and systems approaches$2,147,504
U01 · FY2022 · AG
Therapeutic target discovery in ADSP data via comprehensive whole-genome analysis incorporating ethnic diversity and systems approaches$32,137
U01 · FY2022 · AG
The Baylor-Hopkins Clinical Genomics Center for All of Us$44,470,704
OT2 · FY2021 · OD
Therapeutic target discovery in ADSP data via comprehensive whole-genome analysis incorporating ethnic diversity and systems approaches$2,153,560
U01 · FY2021 · AG
ImplementatioN ScIence for Genomic Health Translation (INSIGHT)$443,629
R21 · FY2021 · HG · contact PI
Therapeutic target discovery in ADSP data via comprehensive whole-genome analysis incorporating ethnic diversity and systems approaches$128,552
U01 · FY2021 · AG
Therapeutic target discovery in ADSP data via comprehensive whole-genome analysis incorporating ethnic diversity and systems approaches$112,663
U01 · FY2021 · AG
The Baylor-Hopkins Clinical Genomics Center for All of Us$42,340,000
OT2 · FY2020 · OD
Therapeutic target discovery in ADSP data via comprehensive whole-genome analysis incorporating ethnic diversity and systems approaches$2,158,021
U01 · FY2020 · AG
Epigenetics of Successful Aging$716,716
R01 · FY2020 · HL · contact PI
The Baylor-Hopkins Clinical Genomics Center for All of Us$13,855,000
OT2 · FY2019 · OD
Therapeutic target discovery in ADSP data via comprehensive whole-genome analysis incorporating ethnic diversity and systems approaches$2,164,820
U01 · FY2019 · AG
Epigenetics of Successful Aging$657,871
R01 · FY2019 · HL · contact PI
Epigenetics of Successful Aging$648,107
R01 · FY2019 · HL · contact PI
The Baylor-Hopkins Clinical Genomics Center for All of Us$7,944,175
OT2 · FY2018 · OD
Therapeutic target discovery in ADSP data via comprehensive whole-genome analysis incorporating ethnic diversity and systems approaches$2,233,154
U01 · FY2018 · AG
Epigenetics of Successful Aging$645,704
R01 · FY2018 · HL · contact PI
Epigenetics of Successful Aging$645,704
R01 · FY2018 · HL · contact PI
Sequence-based Discovery of AD Risk & Protective Alleles$951,989
U01 · FY2017 · AG · contact PI
Epigenetics of Successful Aging$690,942
R01 · FY2017 · HL · contact PI
An Integrated Genetic and Epigenetic Approach to Cerebral Small Vessel Disease$609,515
R01 · FY2017 · NS
Sequence-based Discovery of AD Risk & Protective Alleles$951,989
U01 · FY2016 · AG · contact PI
An Integrated Genetic and Epigenetic Approach to Cerebral Small Vessel Disease$602,387
R01 · FY2016 · NS
Sequence-based Discovery of AD Risk & Protective Alleles$937,677
U01 · FY2015 · AG · contact PI
An Integrated Genetic and Epigenetic Approach to Cerebral Small Vessel Disease$602,099
R01 · FY2015 · NS
Sequence-based Discovery of AD Risk & Protective Alleles$997,756
U01 · FY2014 · AG · contact PI
An Integrated Genetic and Epigenetic Approach to Cerebral Small Vessel Disease$641,768
R01 · FY2014 · NS
Modeling DNA Diversity in Reverse Cholesterol Transport$548,502
R01 · FY2012 · HL · contact PI
Modeling DNA Diversity in Reverse Cholesterol Transport$1,146,614
R01 · FY2011 · HL · contact PI
Genomic Approaches to Common Chronic Disease$780,024
P50 · FY2011 · GM · contact PI
Building on GWAS for NHLBI-disease: the CHARGE consortium$15,272,795
RC2 · FY2010 · HL · contact PI
Modeling DNA Diversity in Reverse Cholesterol Transport$1,134,959
R01 · FY2010 · HL · contact PI
Genomic Approaches to Common Chronic Disease$771,201
P50 · FY2010 · GM · contact PI
Building on GWAS for NHLBI-disease: the CHARGE consortium$12,281,613
RC2 · FY2009 · HL · contact PI
Modeling DNA Diversity in Reverse Cholesterol Transport$1,146,693
R01 · FY2009 · HL · contact PI
Genomic Approaches to Common Chronic Disease$766,426
P50 · FY2009 · GM · contact PI
Genetics of Hypertension Associated Treatment "GenHAT"$726,559
R01 · FY2009 · HL · contact PI
GWA for Gene-Environment Interaction Effects Influencing CHD$533,968
U01 · FY2009 · HG · contact PI
MOLECULAR EPIDEMIOLOGY OF ESSENTIAL HYPERTENSION$1,321,445
R37 · FY2008 · HL · contact PI
Modeling DNA Diversity in Reverse Cholesterol Transport$987,292
R01 · FY2008 · HL · contact PI
GWA for Gene-Environment Interaction Effects Influencing CHD$841,563
U01 · FY2008 · HG · contact PI
Genomic Approaches to Common Chronic Disease$754,330
P50 · FY2008 · GM · contact PI
Genome-Wide Association for Loci Influencing CHD and Other Heart, Lung and Blood$593,808
R01 · FY2008 · HL · contact PI
Genetics of Hypertension Associated Treatment "GenHAT"$508,149
R01 · FY2008 · HL · contact PI
Atherosclerosis, Plaque and CVD in Communities$2,376,532
U01 · FY2007 · HL · contact PI
MOLECULAR EPIDEMIOLOGY OF ESSENTIAL HYPERTENSION$1,309,398
R37 · FY2007 · HL · contact PI
The Family Blood Pressure Program (GENOA Network)$1,232,939
U01 · FY2007 · HL · contact PI
Genomic Approaches to Common Chronic Disease$1,144,452
P50 · FY2007 · GM · contact PI
Genome-Wide Association for Loci Influencing CHD and Other Heart, Lung and Blood$371,775
R01 · FY2007 · HL · contact PI
GWA for Gene-Environment Interaction Effects Influencing CHD$257,253
U01 · FY2007 · HG · contact PI
Genetics of Hypertension Associated Treatment "GenHAT"$147,885
R01 · FY2007 · HL · contact PI
Atherosclerosis, Plaque and CVD in Communities$3,328,404
U01 · FY2006 · HL · contact PI
Genome-Wide Association for Loci Influencing CHD$2,734,414
R01 · FY2006 · HL · contact PI
The Family Blood Pressure Program (GENOA Network)$1,384,170
U01 · FY2006 · HL · contact PI
MOLECULAR EPIDEMIOLOGY OF ESSENTIAL HYPERTENSION$1,306,995
R37 · FY2006 · HL · contact PI
Modeling DNA Diversity in Reverse Cholesterol Transport$1,191,075
R01 · FY2006 · HL · contact PI
Gene-environment interaction in complex disease$408,956
R01 · FY2006 · HL · contact PI
The Family Blood Pressure Program (GENOA Network)$5,500
U01 · FY2006 · HL · contact PI
Atherosclerosis, Plaque and CVD in Communities$5,561,975
U01 · FY2005 · HL
MOLECULAR EPIDEMIOLOGY OF ESSENTIAL HYPERTENSION$1,297,879
R37 · FY2005 · HL
Modeling DNA Diversity in Reverse Cholesterol Transport$1,187,174
R01 · FY2005 · HL
The Family Blood Pressure Program (GENOA Network)$849,366
U01 · FY2005 · HL
Gene-environment interaction in complex disease$408,707
R01 · FY2005 · HL
Atherosclerosis, Plaque and CVD in Communities$4,368,731
U01 · FY2004 · HL
MOLECULAR EPIDEMIOLOGY OF ESSENTIAL HYPERTENSION$1,197,902
R37 · FY2004 · HL
Modeling DNA Diversity in Reverse Cholesterol Transport$1,152,596
R01 · FY2004 · HL
GENETIC DETERMINANTS OF HIGH BP IN THREE RACIAL GROUPS$604,637
U01 · FY2004 · HL
Gene-environment interaction in complex disease$359,195
R01 · FY2004 · HL
Modeling DNA Diversity in Reverse Cholesterol Transport$1,095,811
R01 · FY2003 · HL
MOLECULAR EPIDEMIOLOGY OF ESSENTIAL HYPERTENSION$1,020,681
R37 · FY2003 · HL
GENETIC DETERMINANTS OF HIGH BP IN THREE RACIAL GROUPS$603,327
U01 · FY2003 · HL
MOLECULAR EPIDEMIOLOGY OF ESSENTIAL HYPERTENSION$1,115,332
R37 · FY2002 · HL
GENETIC DETERMINANTS OF HIGH BP IN THREE RACIAL GROUPS$643,905
U01 · FY2002 · HL
MOLECULAR EPIDEMIOLOGY OF ESSENTIAL HYPERTENSION$74,831
R37 · FY2002 · HL
Population based genotyping$0
P50 · FY2002 · GM
MOLECULAR EPIDEMIOLOGY OF ESSENTIAL HYPERTENSION$1,079,567
R37 · FY2001 · HL
GENETIC DETERMINANTS OF HIGH BP IN THREE RACIAL GROUPS$653,080
U01 · FY2001 · HL
Population based genotyping$0
P50 · FY2001 · GM
MOLECULAR EPIDEMIOLOGY OF ESSENTIAL HYPERTENSION$1,067,858
R37 · FY2000 · HL
GENETIC DETERMINANTS OF HIGH BP IN THREE RACIAL GROUPS$676,658
U01 · FY2000 · HL
FUNCTIONAL GENOMICS OF ARTERIAL THROMBOSIS$396,716
R01 · FY2000 · NS